BREAKTHROUGH MARKETING, INC. — TTAB Proceedings
BREAKTHROUGH MARKETING, INC. is a party to 3 TTAB proceedings.
Proceedings
- Proceeding 78445304 — Extensions of Time to Oppose, Terminated (filed 2005-07-05) against Western Holdings, LLC as defendant
- Proceeding 78418770 — Extensions of Time to Oppose, Terminated (filed 2005-04-19) against Pfizer Inc. as defendant
- Proceeding 78420138 — Extensions of Time to Oppose, Terminated (filed 2005-04-29) against Hoffmann-La Roche Inc as defendant
Marks in These TTAB Matters
Common TTAB Counterparties
- Hoffmann-La Roche Inc — 1 proceedings
- Pfizer Inc. — 1 proceedings
- Western Holdings, LLC — 1 proceedings
Recent TTAB Timeline
- 2005-08-05: 78445304 — EXTENSION OF TIME GRANTED involving Western Holdings, LLC
- 2005-08-05: 78445304 — INCOMING - EXT TIME TO OPPOSE FILED involving Western Holdings, LLC
- 2005-07-05: 78445304 — EXTENSION OF TIME GRANTED involving Western Holdings, LLC
- 2005-07-05: 78445304 — INCOMING - EXT TIME TO OPPOSE FILED involving Western Holdings, LLC
- 2005-06-13: 78420138 — SUBMITTED ON BRIEF involving Hoffmann-La Roche Inc
- 2005-06-03: 78420138 — EXTENSION OF TIME GRANTED involving Hoffmann-La Roche Inc
- 2005-06-02: 78418770 — EXTENSION OF TIME GRANTED involving Pfizer Inc.
- 2005-06-02: 78418770 — INCOMING - EXT TIME TO OPPOSE FILED involving Pfizer Inc.
- 2005-05-31: 78420138 — INCOMING - EXT TIME TO OPPOSE FILED involving Hoffmann-La Roche Inc
- 2005-04-29: 78420138 — EXTENSION OF TIME GRANTED involving Hoffmann-La Roche Inc
- 2005-04-29: 78420138 — INCOMING - EXT TIME TO OPPOSE FILED involving Hoffmann-La Roche Inc
- 2005-04-22: 78418770 — EXTENSION OF TIME GRANTED involving Pfizer Inc.
- 2005-04-22: 78418770 — INCOMING - EXT TIME TO OPPOSE FILED involving Pfizer Inc.
- 2005-04-22: 78418770 — EXTENSION OF TIME GRANTED involving Pfizer Inc.
- 2005-04-22: 78418770 — INCOMING - EXT TIME TO OPPOSE FILED involving Pfizer Inc.
- 2005-04-19: 78418770 — EXTENSION OF TIME GRANTED involving Pfizer Inc.
- 2005-04-19: 78418770 — INCOMING - EXT TIME TO OPPOSE FILED involving Pfizer Inc.